Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247390 · ClinicalTrials.gov registry record · Phase 3
Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.
A Phase 3 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 451
- Enrollment target
NCT00247390 is a Phase 3 study that has completed, run by Takeda. The registered enrollment target is 451 participants.
The verdict
NCT00247390, a Phase 3 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 451 participants
- Enrollment target
Study Summary
The purpose of this study to determine the long-term efficacy and safety of ramelteon, once daily (QD).
Interventions
- DRUG Placebo
- DRUG Ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2005-07 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00247390
The ClinicalTrials.gov registry entry for NCT00247390 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 451 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00247390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00247390 about?
NCT00247390 is a clinical study titled "Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.". The purpose of this study to determine the long-term efficacy and safety of ramelteon, once daily (QD).
What is the current status of trial NCT00247390?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 451 participants. The study started on 2005-07. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00247390?
The interventions under investigation include: Placebo (DRUG), Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00247390?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.